127 related articles for article (PubMed ID: 34968728)
1. Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases.
Baiges A; Cerda E; Amicone C; Téllez L; Alvarado-Tapias E; Puente A; Fortea JI; Llop E; Rocha F; Orts L; Ros-Fargas O; Vizcarra P; Zekrini K; Lounes OA; Touati G; Jiménez-Esquivel N; Serrano MJ; Falgà A; Magaz M; Olivas P; Betancourt F; Perez-Campuzano V; Turon F; Payancé A; Goria O; Rautou PE; Hernández-Gea V; Villanueva C; Albillos A; Plessier A; García-Pagán JC
Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1525-1533.e5. PubMed ID: 34968728
[TBL] [Abstract][Full Text] [Related]
2. Splanchnic vein thrombosis associated with SARS-CoV-2 infection: A VALDIG case-control study.
Deltenre P; Payancé A; Elkrief L; La Mura V; Artru F; Baiges A; Cervoni JP; China L; Colle I; Lemaitre E; Procopet B; Schiller D; Bureau C; Goria O; Ollivier I; Nuzzo A; Rautou PE; Plessier A;
JHEP Rep; 2023 Nov; 5(11):100894. PubMed ID: 37841638
[TBL] [Abstract][Full Text] [Related]
3. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
[TBL] [Abstract][Full Text] [Related]
5. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and liver disease: mechanistic and clinical perspectives.
Marjot T; Webb GJ; Barritt AS; Moon AM; Stamataki Z; Wong VW; Barnes E
Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):348-364. PubMed ID: 33692570
[TBL] [Abstract][Full Text] [Related]
7. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
[TBL] [Abstract][Full Text] [Related]
9. Hospital mortality in patients with rare diseases during pandemics: lessons learnt from the COVID-19 and SARS pandemics.
Chung CCY; Wong WHS; Chung BHY
Orphanet J Rare Dis; 2021 Aug; 16(1):361. PubMed ID: 34384469
[TBL] [Abstract][Full Text] [Related]
10. Risk of severe disease and mortality of COVID-19 in patients with Budd-Chiari syndrome: A population-based matched cohort study.
Krishnan A; Schneider CV; Schattenberg JM; Alqahtani SA
Liver Int; 2023 May; 43(5):1141-1144. PubMed ID: 36825357
[TBL] [Abstract][Full Text] [Related]
11. Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients.
Ponziani FR; Del Zompo F; Nesci A; Santopaolo F; Ianiro G; Pompili M; Gasbarrini A;
Aliment Pharmacol Ther; 2020 Sep; 52(6):1060-1068. PubMed ID: 32628793
[TBL] [Abstract][Full Text] [Related]
12. Acute splanchnic vein thrombosis in patients with COVID-19: A systematic review.
Buso G; Becchetti C; Berzigotti A
Dig Liver Dis; 2021 Aug; 53(8):937-949. PubMed ID: 34120860
[TBL] [Abstract][Full Text] [Related]
13. Splanchnic venous thrombosis in a nephrotic patient following COVID-19 infection: a case report.
Hussein MH; Alabdaljabar MS; Alfagyh N; Badran M; Alamiri K
BMC Nephrol; 2021 Dec; 22(1):420. PubMed ID: 34965863
[TBL] [Abstract][Full Text] [Related]
14. PAI-1 4G-4G, MTHFR 677TT, V Leiden 506Q, and Prothrombin 20210A in Splanchnic Vein Thrombosis: Analysis of Individual Patient Data From Three Prospective Studies.
Pasta L; Pasta F; D'Amico M
J Clin Exp Hepatol; 2016 Mar; 6(1):10-4. PubMed ID: 27194890
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 infection in pregnancy during the first wave of COVID-19 in the Netherlands: a prospective nationwide population-based cohort study (NethOSS).
Overtoom EM; Rosman AN; Zwart JJ; Vogelvang TE; Schaap TP; van den Akker T; Bloemenkamp K
BJOG; 2022 Jan; 129(1):91-100. PubMed ID: 34494694
[TBL] [Abstract][Full Text] [Related]
16. Low risk of nosocomial severe acute respiratory syndrome-coronavirus-2 infection in patients with liver disease admitted to a hepatology unit at an academic hospital: A single-center experience.
Toniutto P; D'Aurizio F; Cmet S; Cussigh A; Falleti E; Fabris C; Sartor E; Fornasiere E; Fumolo E; Bitetto D; Curcio F
Indian J Gastroenterol; 2022 Jun; 41(3):292-299. PubMed ID: 35768749
[TBL] [Abstract][Full Text] [Related]
17. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
[TBL] [Abstract][Full Text] [Related]
18. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
[TBL] [Abstract][Full Text] [Related]
19. Early comprehensive testing for COVID-19 is essential to protect trauma centers.
Hu P; Jansen JO; Uhlich R; Black J; Pierce V; Hwang J; Northern D; Stephens SW; Lee RA; Gelbard RB; Holcomb JB; Kerby J; Cox D;
J Trauma Acute Care Surg; 2020 Oct; 89(4):698-702. PubMed ID: 32618968
[TBL] [Abstract][Full Text] [Related]
20. Anesthetic Complications Associated With Severe Acute Respiratory Syndrome Coronavirus 2 in Pediatric Patients.
Saynhalath R; Alex G; Efune PN; Szmuk P; Zhu H; Sanford EL
Anesth Analg; 2021 Aug; 133(2):483-490. PubMed ID: 33886516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
